88 related articles for article (PubMed ID: 12461279)
1. Breast carcinoma metastases to the liver simulating cirrhosis.
Burkill GJ; King LJ; Scurr E; Healy JC
Radiology; 2002 Dec; 225(3):917; author reply 917-8. PubMed ID: 12461279
[No Abstract] [Full Text] [Related]
2. Contrast-enhanced MR imaging of the liver.
Saini S
Radiology; 1992 Jan; 182(1):12-4. PubMed ID: 1727273
[No Abstract] [Full Text] [Related]
3. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
Steudel A; Layer G; Kraheck H; Hartlapp J; Reiser M
Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550
[TBL] [Abstract][Full Text] [Related]
4. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
5. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Kopp AF; Laniado M; Aicher KP; Grönewäller EF; Claussen CD
Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
Sheppard D; Allan L; Martin P; McLeay T; Milne W; Houston JG
J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
[TBL] [Abstract][Full Text] [Related]
7. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Rofsky NM; Earls JP
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
[TBL] [Abstract][Full Text] [Related]
9. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
[TBL] [Abstract][Full Text] [Related]
10. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
11. Re: diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Bryant M; Higginson A
Clin Radiol; 2007 Aug; 62(8):817; author reply 817. PubMed ID: 17604776
[No Abstract] [Full Text] [Related]
12. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Rofsky NM; Weinreb JC; Bernardino ME; Young SW; Lee JK; Noz ME
Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
[TBL] [Abstract][Full Text] [Related]
14. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy.
Lee VS; Rofsky NM; Morgan GR; Teperman LW; Krinsky GA; Berman P; Weinreb JC
AJR Am J Roentgenol; 2001 Apr; 176(4):906-8. PubMed ID: 11264075
[No Abstract] [Full Text] [Related]
15. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
[TBL] [Abstract][Full Text] [Related]
16. Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of "pseudocirrhosis".
Sass DA; Clark K; Grzybicki D; Rabinovitz M; Shaw-Stiffel TA
Dig Dis Sci; 2007 Mar; 52(3):749-52. PubMed ID: 17265127
[No Abstract] [Full Text] [Related]
17. Adrenal gland enhancement at MR imaging with Mn-DPDP.
Mitchell DG; Outwater EK; Matteucci T; Rubin DL; Chezmar JL; Saini S
Radiology; 1995 Mar; 194(3):783-7. PubMed ID: 7862979
[TBL] [Abstract][Full Text] [Related]
18. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Guo T; Zhang XL; Chang RM; Zhang YZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
Gehl HB; Vorwerk D; Klose KC; Günther RW
Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
